Immuneering Corporation (IMRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immuneering Corporation

    NASDAQ: IMRX · Real-Time Price · USD
    7.05
    1.10 (18.49%)
    At close: Sep 09, 2025, 3:59 PM
    7.05
    0.00%
    Pre-market: Sep 10, 2025, 06:11 AM EDT

    Immuneering Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 316.95K 2.08M
    Cost of Revenue
    		 713.45K 764.14K 158.12K 1.15M
    Gross Profit
    		 -713.45K -764.14K 158.83K 926.89K
    Operating Income
    		 -64.07M -58.41M -51.74M -33.89M
    Interest Income
    		 2.59M 3.61M 1.01M 169.9K
    Pretax Income
    		 -61.04M -53.47M -50.51M -33.84M
    Net Income
    		 -61.04M -53.47M -49.28M -33.54M
    Selling & General & Admin
    		 16.08M 16.25M 15.61M 8.27M
    Research & Development
    		 47.96M 41.4M 36.27M 26.54M
    Other Expenses
    		 29K n/a 30.05K -127.06K
    Operating Expenses
    		 64.07M 57.65M 51.9M 34.81M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a -511.87K n/a n/a
    Cost & Expenses
    		 64.07M 58.41M 52.06M 35.97M
    Income Tax Expense
    		 n/a n/a -1.23M -307.49K
    Shares Outstanding (Basic)
    		 29.98M 28.42M 26.39M 26.32M
    Shares Outstanding (Diluted)
    		 29.98M 28.42M 26.39M 26.32M
    EPS (Basic)
    		 -2.04 -1.88 -1.87 -1.27
    EPS (Diluted)
    		 -2.04 -1.88 -1.87 -1.27
    EBITDA
    		 -63.69M -58.06M -51.47M -33.68M
    EBIT
    		 -64.07M -58.41M -51.75M -33.89M
    Depreciation & Amortization
    		 385.07K 352.08K 796.79K 159.07K

    Add to Watchlist